Concepedia

Anja Eberl

AE

Statistics

Publications

6

Citations

201

H-Index

6

Active since

2017

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

ESiOR Oy (Finland)

Janssen (United Kingdom)

Vaasa Central Hospital

Anja Eberl is an author at Helsinki University Hospital specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and crohn disease pharmacotherapy.

ORCID

Publications per year

2017–2021

6

Publications

6

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease

Rebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib et al. · Journal of Crohn s and Colitis · 2020 · 67 citations · Full text

, , +17

Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)

Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten et al. · Scandinavian Journal of Gastroenterology · 2019 · 48 citations · Full text

, , +17

Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

Anja Eberl, Saara Huoponen, Tapio Pahikkala et al. · Scandinavian Journal of Gastroenterology · 2017 · 31 citations · Full text

, , +17

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort

Clas-Göran af Björkesten, Tuire Ilus, Taru Hallinen et al. · European Journal of Gastroenterology & Hepatology · 2020 · 20 citations · Full text

, , +13

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland

Taina Sipponen, Clas-Göran af Björkesten, Taru Hallinen et al. · Scandinavian Journal of Gastroenterology · 2021 · 20 citations · Full text

, , +15

1–5 of 6